1. Home
  2. LQDA vs FFIN Comparison

LQDA vs FFIN Comparison

Compare LQDA & FFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$68.49

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo First Financial Bankshares Inc.

FFIN

First Financial Bankshares Inc.

HOLD

Current Price

$32.46

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
FFIN
Founded
2004
1890
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.9B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
LQDA
FFIN
Price
$68.49
$32.46
Analyst Decision
Strong Buy
Hold
Analyst Count
11
2
Target Price
★ $41.00
$36.50
AVG Volume (30 Days)
★ 963.9K
653.8K
Earning Date
05-08-2026
04-16-2026
Dividend Yield
N/A
★ 2.39%
EPS Growth
★ 51.81
13.46
EPS
★ 1.26
1.00
Revenue
★ $158,320,000.00
N/A
Revenue This Year
$278.87
$17.16
Revenue Next Year
$57.13
$6.61
P/E Ratio
$56.31
★ $32.17
Revenue Growth
★ 1031.18
N/A
52 Week Low
$21.35
$28.12
52 Week High
$93.61
$36.52

Technical Indicators

Market Signals
Indicator
LQDA
FFIN
Relative Strength Index (RSI) 47.51 41.18
Support Level $62.86 $32.30
Resistance Level $92.35 $32.98
Average True Range (ATR) 2.78 0.60
MACD 0.69 -0.04
Stochastic Oscillator 66.74 40.49

Price Performance

Historical Comparison
LQDA
FFIN

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About FFIN First Financial Bankshares Inc.

First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.

Share on Social Networks: